Login
$NBIX
$165.31 +$0.00 (0.0%) After hours

$NBIX SEC Filings

Filed On Filing
10 Nov 2026 144
05 Nov 2026 Form 4: Roberts Eiry, Chief Medical Officer

Granted 8,314 Stock Option · Granted 1,506 Restricted Stock Unit

03 Nov 2026 Form 4: Morrow George J, Director

Received 300 shares by exercise or conversion ($16.1K) · Sold 300 shares ($44.7K) · Received 7,500 shares by exercise or conversion ($402K) · 3 more

03 Nov 2026 Form 4: Gano Kyle, Director

Received 614 shares by exercise or conversion · Gave up 332 shares to cover exercise price or tax ($48.5K)

02 Nov 2026 144
02 Nov 2026 10-Q
02 Nov 2026 8-K: Results of Operations and Financial Condition

Total Third-Quarter 2026 Revenue Grew 41% Year-Over-Year to $1.1 Billion

30 Oct 2026 144
30 Oct 2026 SCHEDULE 13G
15 Oct 2026 SCHEDULE 13G/A
07 Oct 2026 Form 3: Roberts Eiry, Chief Medical Officer

Holds 51,331 shares of Common Stock

28 Sep 2026 8-K: Departure/Election of Directors or Officers; Compensation

On September 28, 2026, the Board of Directors (the “Board”) of Neurocrine Biosciences, Inc. (the “Company”) appointed Eiry W. Roberts, M.D., to succeed Sanjay Keswani, M.D., as the Company’s Chief Medical Officer, effective September 28,...

15 Sep 2026 Form 4: Onyia Jude, Chief Scientific Officer

Received 3,587 shares as a grant or award · Gave up 1,936 shares to cover exercise price or tax ($302K)

15 Sep 2026 Form 4: Lippoldt Darin, Chief Legal Officer

Received 4,483 shares as a grant or award · Gave up 2,419 shares to cover exercise price or tax ($378K)

15 Sep 2026 Form 4: Keswani Sanjay Chandru, Chief Medical Officer

Received 3,914 shares as a grant or award · Gave up 2,112 shares to cover exercise price or tax ($330K)

15 Sep 2026 Form 4: Gorman Kevin Charles, Director

Received 14,343 shares as a grant or award · Gave up 7,839 shares to cover exercise price or tax ($1.22M)

15 Sep 2026 Form 4: Gano Kyle, Director

Received 8,117 shares as a grant or award · Gave up 4,380 shares to cover exercise price or tax ($684K)

15 Sep 2026 Form 4: Delaet Ingrid, Chief Regulatory Officer

Received 4,483 shares as a grant or award · Gave up 2,419 shares to cover exercise price or tax ($378K)

15 Sep 2026 Form 4: Cooke Julie, Chief Human Resources Officer

Received 3,587 shares as a grant or award · Gave up 1,936 shares to cover exercise price or tax ($302K)

15 Sep 2026 Form 4: Boyer David W., Chief Corp. Affairs Officer

Received 3,587 shares as a grant or award · Gave up 1,936 shares to cover exercise price or tax ($302K) · Sold 826 shares ($130K)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support